IL6 and chronic kidney disease: Clinical studies demonstrate that elevated serum IL-6 levels in CKD patients correlate with coronary artery calcification (CAC) progression and cardiovascular mortality, with high IL-6 tertiles exhibiting a 2.2-fold increased risk of death (38).